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Molecular heterogeneity of the CFI'R gene has been largely reported, being 
missense mutations the most frequently found. This study was undertaken to 
functionally analyze 8 missense changes mostly identified ha Spanish patients with 
CF or CFFR related disease. Thus, we have generated 4 mutations on the NH 2 
terminal intr acellular domain (P5L, S50R E60K, R75Q) and 4 mutations on the first 
transmembrane domain (TM1) (G85E, G85V, Y89C, E92K), using site<lirected 
mutagenesis over the pCMVNot6.2 plasmid*, which contains the wi ld type CFI'R 
cDNA. Transient non viral transfection was performed on HEK293 cells. The 
maturation pattern of mutant proteins was analyzed by western blot. The P5L, R75Q 
and Y89C mutants showed an electrophoretic pattern similar to the wi ld type 
CFTR, although, the amount of completely glycosylated protein was lower ha 
mutants. The other mutations produced only partially glycosylated proteins. We 
assessed the cellular localization of the different mutants by immtmofluorescence. 
Mutations leading to partially glycosylated proteins did not reach the cell 
membrane, and were detected mostly on the endoplasmatic reticulum. Recordings 
obtained by whole  cel l  patch c lamp matched the results obtained by 
immtmofluorescence and immtmoblotting. The single channel technique is being 
performed currently to analyze the activity of the CFFR mutant proteins that were 
able to reach the cell membrane (P5L, R75Q and Y89C) to elucidate the functional 
state of the corresponding channels. 
*Kindly provided by Dr. Rommens (Toronto). 
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Glycos3,1ation f CFFR has been described as a maj or determinant in the acquisition 
of native structure, mediating the interaction with the molecular chaperone calnexin 
that is also involved in the ER quality control (ERQC). We have replaced 
asparagines 894 and 900 (N glycosylation sites) on both wt and F508del CFTR by 
either alanines or glutamines and studied the turnover, localization and function of 
these mutants. 
Substitutions were performed by site directed mutagenesis and stable transfectants 
of BHK cells were produced. Turnover of the mutants was studied by pulse chase 
analysis fol lowed by CFTR immunoprecipit ation (IP), intracellular localization was 
investigated by immunccyt cchemistry (ICC) and their channel activity assessed by 
the iodide eff iux assay (lEA). 
For all these variants, only band A is observed, due to the complete absence of N 
glycosylation. The turnover of wt  CFFR with two alanines (WAA) or two 
glutamines (WQQ) is significantly increased, most probably due to increased 
degradation. Analy sis of F508del CFTR with two alanines (FAA) or two glutamines 
(FQQ) also revealed a significantly increase in turnover elatively to F508del 
CFIR.  
ICC shows that CF IR  WQQ, (but not CFTR WAA, FAA or FQQ) is present at the 
membrane mad consistently, IF& evidenced that only CFFR WQQ exhibt s channel 
activity mad that this is similar to that of wt  CFTR. 
These data reinforce the role of the N~lycosylat ion on the calnexin mediated 
folding and stability of CF IR  but also support the existence of a glycan 
independent degradation pathway for CFFR. 
Further characterization f the trafficking (WQQ) and ERQC pathways responsible 
for the behaviour observed for these glycos3'lation null  mutants is currently 
underway. 
Supported by POCFIfMGI/47382/2CO2 grant (FCF, Portugal) 
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The switch motif  ha the nucleotide binding domain s important for the function of 
several bacterial ABC transporters where it is required for the steps subsequent to 
ATP binding mad hydrolysis. However, the function of this motif  ha CFTR, the only 
ion channel among the ABC proteins, remains unknown. We have previously 
reported that the amino acids ha this region affect the aggregation rate of the CFFR 
derived C terminal peptides. The aim of this study was to test whether the switch 
motif  plays a role in the maturation and chloride channel function of the ful l  ength 
CFTR. In vitro mutagenesis was used to introduce specific mutations into the NBD2 
domain of CFFR. The deletion of the entire switch motif  region ha NBD2 resulted 
in production of a partial ly glycosylated protein that was retained ha the 
endoplasmic reticulum mad did not reach the cell s~rface. On the other hand, the 
introduction of the CF causing (V1397E) or artif icial (H1402A, R1403A) 
substitutions ofconserved amino acids within the switch motif  did not interfere with 
the maturation prc~ess of CFTR. These results suggest that the NBD fragment 
encompassing the switch motif  is required for proper folding and maturation of 
CFTR, although certain conserved amino acids within this motif  can be substituted 
without disrupting the protein prc~essing. Prel iminary patch clamp studies 
performed on HEK293 cells expressing the H1402A,R1403A CFTR protein show 
that the chloride conductance generated by this mutated channel is ower than that 
of wi ld type CFFR but higher than in the case of AF508. 
Supported by the KBN grant 3FO5A 069 23. 
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In order to identify news proteins that might interact with CFTR and modify the 
pr c~essing of the protein, we  performed a yeast wo hybrid screening with the third 
cytoplasmic loop (CL3) of CFFR as a bait. CSN5/Jabl,  the fifth component of the 
COP9 signalosome, was found to interact with CL3. This interaction was later 
tested in yeast with class II mutants of CL3 ($945L, H949Y and D979A)  and a loss 
of interaction was observed with one of them. 
In vivo experiments howed that CSN5/Jabl  and CF IR  could be coimmtmo 
precipitated from HeLa cells stably expressing wt or delF508 CFTR. Our results 
show that the direct interaction between CFTR and CSN5/Jabl is strongest with 
delF508 than with wt CFIR.  
Cellular localization of CSN5/Jabl is wide: i) as a component of the signalosome, 
it is predominantly in the nucleus, i i) as a monomer it is both ha the nucleus and the 
cytoplasm and ii i) as a small loose complex ha the cytoplasm. Thus, we  have looked 
at the localization of CSN5/Jabl in the presence of wt or delF508 CFFR ha HeLa 
cells and observed ifferent patterns. 
CSN5/Jabl is able to interact with a variety of signaling molecules and is a regulator 
of their stability in mammal ian cells. We are studying the over expression 
(tr ansfection) and the down-expression (siRNA) of CSN5/Jabl on the processing of 
wt  and delF508 CF IR  by pulse chase and in vitrolphosphorylation experiments. In
addition, it is known that CSN5/Jabl activity is inhibited by curcumin and that this 
drug might improve CFTR delF508 prccessing toward the plasma membrane. We 
are therefore testing the effect of curcumin combined with CSN5/Jabl on CF IR  
pr ccessing. 
We have identified CSN5/Jabl as a partner of CFFR but further studies are 
necessary to investigate the functional role of CSN5/Jabl on CFFR processing and 
how it could be targeted for a therapeutic benefit of cystic fibrosis. 
This work was supported by grants from INSERM, Vaincre la Mucovis~idose and 
Chancellerie des Universit6s de paris. 
